2-(Fluoromethoxy)-4 ‘-(S-methanesulfonimidoyl)-1,1 ‘-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D-1 Receptor for Parkinson’s Disease.

Garcia-Carceles, J; Vazquez-Villa, H; Brea, J; De Guevara-Miranda, DL; Cincilla, G; Sanchez-Martinez, M; Sanchez-Merino, A; Algar, S; De los Frailes, MT; Roberts, RS; Ballesteros, JA; De Fonseca, FR; Benhamu, B; Loza, MI; Lopez-Rodriguez, ML – 2022